MONASH University Professor of
Immunology, Charles Mackay has
been awarded the annual
GlaxoSmithKline Australia Award
for Research Excellence 2010.
An Australian Fellow Mackay has
published more than 135 papers
(together cited over 20,000 times),
the majority of which deal with the
role and utility of chemoattractant
receptors for understanding biology
and developing new treatments.
Most recently Mackay’s research
group identified GPR43 as a major
regulator of innate and
inflammatory response.
For his years of effort Mackay has
received $60,000 worth of funding
from GSK to further his knowledge
and research.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Aug 10
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.